Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $856,413 - $1.34 Million
-87,300 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $193,440 - $234,880
-16,000 Reduced 15.49%
87,300 $1.18 Million
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $757,900 - $865,436
-57,200 Reduced 35.64%
103,300 $1.4 Million
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $350,190 - $436,049
-27,000 Reduced 14.4%
160,500 $2.29 Million
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $2.55 Million - $3.48 Million
187,500 New
187,500 $2.62 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.3B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.